November 18, 2016 @ 7:32 pm | IONS, Jubak Picks Portfolio, Update |
Sometimes the importance of a clinical trial extends way beyond the specific drug under study. That’s the case with the Phase II data recently released by Ionis for FIXRx. The trial did show efficacy in the treatment of kidney disease. But the most important...